Legal Risks Complicate Drugmakers' TrumpRx Participation
By Dan McKay · February 3, 2026, 3:02 PM EST
A federal watchdog issued a rare bulletin last week — its first in almost 12 years — assuring drugmakers that they can sell directly to patients through the planned TrumpRx site without facing...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login